首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >Neuroprotective effect of quercetin in neurotoxicity induced rats: role of neuroinflammation in neurodegeneration
【24h】

Neuroprotective effect of quercetin in neurotoxicity induced rats: role of neuroinflammation in neurodegeneration

机译:槲皮素对神经毒性大鼠的神经保护作用:神经炎症在神经变性中的作用

获取原文
获取外文期刊封面目录资料

摘要

Objective: To study the neuroprotective effect of quercetin in animal model of neurodegeneration. Methods: Quercetin (3,5,7,3’,4’- pentahydroxy flavones) is a potential compound having both anti-inflammatory and anti-oxidant properties with low gastric and cardiac side effect. Different COX-2 inhibitors like nimesulide, refecoxib and celecoxib have been proved to have their neuroprotective action in different animal models of neurodegenerative disorders but they are burdened with high toxicity. Different neurodegenerative models like haloperidol induced catalepsy, Reserpine induced vacuous chewing movements and MPTP (1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine)induced neurodegeneration were evaluated with Levadopa at a dose of (30 mg/kg i.p.) and Quercetin at a dose of (25 mg/kg, p.o.) as standard and test drugs respectively. Results: In the haloperidol induced catalepsy model the increased cataleptic score was significantly reduced with both the standard drug Levodopa and the test drug Quercetin. The increased frequencies of vacuous chewing movements on administration of Reserpine were reversed with the treatment of Quercetin. The reduced actophotometer activity score due to Reserpine was significantly reversed by Quercetin. The decreased level of lipid per-oxidation and increased glutathione concentration by the administration of Quercetin which reversed the toxicity of MPTP. Conclusion: Quercetin is a potential compound having both anti-inflammatory and anti-oxidant properties. These effects of enlights the pharmacodynamic pathway of neuroprotective properties of Quercetin in animal model study.
机译:目的:研究槲皮素对神经退行性动物模型的神经保护作用。方法:槲皮素(3,5,7,3',4'-五羟基黄酮)是一种具有消炎和抗氧化特性的潜在化合物,具有较低的胃和心脏副作用。事实证明,在不同的神经退行性疾病动物模型中,不同的COX-2抑制剂(如尼美舒利,瑞非昔布和塞来昔布)具有神经保护作用,但它们具有高毒性。用左旋多巴(30 mg / kg ip ip)评估了氟哌啶醇诱导的僵直性僵直,利血平诱导的空腹咀嚼运动和MPTP(1-甲基-4-苯基-1,2,3,6-四氢吡啶)诱导的神经变性的不同神经退行性模型)和槲皮素(分别为25 mg / kg,口服)作为标准药物和测试药物。结果:在氟哌啶醇诱导的僵直症模型中,标准药物左旋多巴和测试药物槲皮素均显着降低了增加的僵化分数。槲皮素治疗可逆转利血平给药后空腹咀嚼运动的频率增加。槲皮素可以显着逆转由于利血平引起的光度计活性降低。槲皮素的给药降低了脂质过氧化水平,增加了谷胱甘肽浓度,从而逆转了MPTP的毒性。结论:槲皮素是一种具有抗炎和抗氧化特性的潜在化合物。这些作用启发了槲皮素在动物模型研究中神经保护特性的药效动力学途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号